SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector
- PMID: 33065265
- PMCID: PMC7553871
- DOI: 10.1016/j.micinf.2020.10.005
SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector
Conflict of interest statement
Conflicts of interest The authors have no conflicts of interest.
Similar articles
-
Mass testing for covid-19 in the UK.BMJ. 2020 Nov 16;371:m4436. doi: 10.1136/bmj.m4436. BMJ. 2020. PMID: 33199289 No abstract available.
-
Assessment of an Online Tool to Simulate the Effect of Pooled Testing for SARS-CoV-2 Detection in Asymptomatic and Symptomatic Populations.JAMA Netw Open. 2020 Dec 1;3(12):e2031517. doi: 10.1001/jamanetworkopen.2020.31517. JAMA Netw Open. 2020. PMID: 33301014 Free PMC article.
-
Simple Questionnaires to Improve Pooling Strategies for SARS-CoV-2 Laboratory Testing.Ann Glob Health. 2020 Nov 18;86(1):148. doi: 10.5334/aogh.3126. Ann Glob Health. 2020. PMID: 33262937 Free PMC article.
-
Screening for SARS-CoV-2: Health Policy Implications in Low- and Middle-Income Countries.Mayo Clin Proc. 2020 Dec;95(12):2606-2608. doi: 10.1016/j.mayocp.2020.10.007. Epub 2020 Oct 15. Mayo Clin Proc. 2020. PMID: 33276834 Free PMC article. Review. No abstract available.
-
Reorganising for COVID-19 Pandemic: A Review of Structural Modifications by the Department of Internal Medicine in Low to Middle-income Countries.J Coll Physicians Surg Pak. 2020 Oct;30(10):176-177. doi: 10.29271/jcpsp.2020.supp2.S176. J Coll Physicians Surg Pak. 2020. PMID: 33291200 Review.
Cited by
-
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future.Crit Rev Clin Lab Sci. 2022 Nov;59(7):445-459. doi: 10.1080/10408363.2022.2045250. Epub 2022 Mar 15. Crit Rev Clin Lab Sci. 2022. PMID: 35289222 Free PMC article. Review.
-
Limitations of COVID-19 testing and case data for evidence-informed health policy and practice.Health Res Policy Syst. 2023 Jan 25;21(1):11. doi: 10.1186/s12961-023-00963-1. Health Res Policy Syst. 2023. PMID: 36698202 Free PMC article. Review.
-
Analysis of compliance issues and influencing factors in the management of BSL-2 laboratories for pathogenic microorganisms in Lishui, China.Front Bioeng Biotechnol. 2025 Aug 8;13:1637056. doi: 10.3389/fbioe.2025.1637056. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40861857 Free PMC article.
-
Case fatality among people with drug-susceptible TB enrolled in a private health sector TB treatment support program in Bihar, India during the first year of the COVID-19 pandemic.PLOS Glob Public Health. 2024 Sep 12;4(9):e0003277. doi: 10.1371/journal.pgph.0003277. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39264895 Free PMC article.
-
Saliva-based methods for SARS-CoV-2 testing in low- and middle-income countries.Bull World Health Organ. 2022 Dec 1;100(12):808-814. doi: 10.2471/BLT.22.288526. Epub 2022 Oct 3. Bull World Health Organ. 2022. PMID: 36466209 Free PMC article.
References
-
- Health Systems Governance Collaborative . 2020. Private sector discussion note: COVID-19 testing.https://hsgovcollab.org/en/node/4508 Available at:
-
- O’Hanlon B., Hellowell M. 2020. Enabling the private health sector in the national response to COVID-19: six Current Policy Challenges. Geneva.
-
- Puri L., Oghor C., Denkinger C., Pai M. Xpert MTB/RIF for tuberculosis testing: access and price in highly privatised health markets. Lancet Global Health. 2016;4:e94–e95. - PubMed
-
- World Health Organization . 2020. Coronavirus disease (COVID-19) situation report 145.https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... Available at.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous